{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:27:25Z","timestamp":1762507645272,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T00:00:00Z","timestamp":1549584000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["113101007"],"award-info":[{"award-number":["113101007"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1007\/s00198-019-04851-9","type":"journal-article","created":{"date-parts":[[2019,2,8]],"date-time":"2019-02-08T11:22:49Z","timestamp":1549624969000},"page":"573-581","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["All-cause mortality with current and past use of antidepressants or benzodiazepines after major osteoporotic and hip fracture"],"prefix":"10.1007","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5776-4971","authenticated-orcid":false,"given":"I. J. A.","family":"de Bruin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Klop","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. E.","family":"Wyers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. A.","family":"Overbeek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P. P. M. M.","family":"Geusens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P. W.","family":"van den Bergh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. H. M.","family":"Driessen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"de Vries","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,8]]},"reference":[{"key":"4851_CR1","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1007\/s00198-006-0172-4","volume":"17","author":"O Johnell","year":"2006","unstructured":"Johnell O, Kanis JA (2006) An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 17:1726\u20131733. \n                    https:\/\/doi.org\/10.1007\/s00198-006-0172-4","journal-title":"Osteoporos Int"},{"key":"4851_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/s00223-015-0089-z","volume":"98","author":"FJB L\u00f6tters","year":"2016","unstructured":"L\u00f6tters FJB, van den Bergh JP, de Vries F, Rutten-van M\u00f6lken MPMH (2016) Current and future incidence and costs of osteoporosis-related fractures in the Netherlands: combining claims data with BMD measurements. Calcif Tissue Int 98:235\u2013243. \n                    https:\/\/doi.org\/10.1007\/s00223-015-0089-z","journal-title":"Calcif Tissue Int"},{"key":"4851_CR3","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1002\/jbmr.2393","volume":"30","author":"D Bliuc","year":"2015","unstructured":"Bliuc D, Alarkawi D, Nguyen TV, Eisman JA, Center JR (2015) Risk of subsequent fractures and mortality in elderly women and men with fragility fractures with and without osteoporotic bone density: the Dubbo osteoporosis epidemiology study. J Bone Miner Res 30:637\u2013646. \n                    https:\/\/doi.org\/10.1002\/jbmr.2393","journal-title":"J Bone Miner Res"},{"key":"4851_CR4","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1002\/jbmr.3118","volume":"32","author":"T Tran","year":"2017","unstructured":"Tran T, Bliuc D, van Geel T, Adachi JD, Berger C, van den Bergh J, Eisman JA, Geusens P, Goltzman D, Hanley DA, Josse RG, Kaiser SM, Kovacs CS, Langsetmo L, Prior JC, Nguyen TV, Center JR (2017) Population-wide impact of non-hip non-vertebral fractures on mortality. J Bone Miner Res 32:1802\u20131810. \n                    https:\/\/doi.org\/10.1002\/jbmr.3118","journal-title":"J Bone Miner Res"},{"key":"4851_CR5","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/j.1532-5415.2000.tb04758.x","volume":"48","author":"M Egan","year":"2000","unstructured":"Egan M, Moride Y, Wolfson C, Monette J (2000) Long-term continuous use of benzodiazepines by older adults in Quebec: prevalence, incidence and risk factors. J Am Geriatr Soc 48:811\u2013816","journal-title":"J Am Geriatr Soc"},{"key":"4851_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.amjopharm.2011.03.001","volume":"9","author":"SU Karkare","year":"2011","unstructured":"Karkare SU, Bhattacharjee S, Kamble P, Aparasu R (2011) Prevalence and predictors of antidepressant prescribing in nursing home residents in the United States. Am J Geriatr Pharmacother 9:109\u2013119. \n                    https:\/\/doi.org\/10.1016\/j.amjopharm.2011.03.001","journal-title":"Am J Geriatr Pharmacother"},{"key":"4851_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00198-017-4290-y","volume":"29","author":"L Vranken","year":"2018","unstructured":"Vranken L, Wyers CE, van der Velde RY, Janzing HM, Kaarsemaker S, Geusens PP, van den Bergh JP (2018) Comorbidities and medication use in patients with a recent clinical fracture at the fracture liaison service. Osteoporos Int 29:397\u2013407. \n                    https:\/\/doi.org\/10.1007\/s00198-017-4290-y","journal-title":"Osteoporos Int"},{"key":"4851_CR8","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/j.jagp.2014.10.002","volume":"23","author":"A Iaboni","year":"2015","unstructured":"Iaboni A, Seitz DP, Fischer HD, Diong CC, Rochon PA, Flint AJ (2015) Initiation of antidepressant medication after hip fracture in community-dwelling older adults. Am J Geriatr Psychiatry 23:1007\u20131015. \n                    https:\/\/doi.org\/10.1016\/j.jagp.2014.10.002","journal-title":"Am J Geriatr Psychiatry"},{"key":"4851_CR9","doi-asserted-by":"publisher","first-page":"963","DOI":"10.2165\/11317660-000000000-00000","volume":"26","author":"J Panula","year":"2009","unstructured":"Panula J, Puustinen J, Jaatinen P, Vahlberg T, Aarnio P, Kivela SL (2009) Effects of potent anticholinergics, sedatives and antipsychotics on postoperative mortality in elderly patients with hip fracture: a retrospective, population-based study. Drugs Aging 26:963\u2013971. \n                    https:\/\/doi.org\/10.2165\/11317660-000000000-00000","journal-title":"Drugs Aging"},{"key":"4851_CR10","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1111\/j.1532-5415.2011.03372.x","volume":"59","author":"A Kragh","year":"2011","unstructured":"Kragh A, Elmst\u00e5hl S, Atroshi I (2011) Older adults' medication use 6 months before and after hip fracture: a population-based cohort study. J Am Geriatr Soc 59:863\u2013868. \n                    https:\/\/doi.org\/10.1111\/j.1532-5415.2011.03372.x","journal-title":"J Am Geriatr Soc"},{"key":"4851_CR11","doi-asserted-by":"publisher","first-page":"d4551","DOI":"10.1136\/bmj.d4551","volume":"343","author":"C Coupland","year":"2011","unstructured":"Coupland C, Dhiman P, Morriss R, Arthur A, Barton G, Hippisley-Cox J (2011) Antidepressant use and risk of adverse outcomes in older people: population based cohort study. BMJ 343:d4551\u2013d4551. \n                    https:\/\/doi.org\/10.1136\/bmj.d4551","journal-title":"BMJ"},{"key":"4851_CR12","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1177\/1060028015625284","volume":"50","author":"RA Hansen","year":"2016","unstructured":"Hansen RA, Khodneva Y, Glasser SP, Qian J, Redmond N, Safford MM (2016) Antidepressant medication use and its association with cardiovascular disease and all-cause mortality in the reasons for geographic and racial differences in stroke (REGARDS) study. Ann Pharmacother 50:253\u2013261. \n                    https:\/\/doi.org\/10.1177\/1060028015625284","journal-title":"Ann Pharmacother"},{"key":"4851_CR13","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1001\/archinternmed.2009.436","volume":"169","author":"JW Smoller","year":"2009","unstructured":"Smoller JW, Allison M, Cochrane BB et al (2009) Antidepressant use and risk of incident cardiovascular morbidity and mortality among postmenopausal women in the Women's Health Initiative study. Arch Intern Med 169:2128\u20132139. \n                    https:\/\/doi.org\/10.1001\/archinternmed.2009.436","journal-title":"Arch Intern Med"},{"key":"4851_CR14","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/j.euroneuro.2015.08.014","volume":"25","author":"P Jennum","year":"2015","unstructured":"Jennum P, Baandrup L, Ibsen R, Kjellberg J (2015) Increased all-cause mortality with use of psychotropic medication in dementia patients and controls: a population-based register study. Eur Neuropsychopharmacol 25:1906\u20131913. \n                    https:\/\/doi.org\/10.1016\/j.euroneuro.2015.08.014","journal-title":"Eur Neuropsychopharmacol"},{"key":"4851_CR15","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.sleep.2008.12.004","volume":"10","author":"L Mallon","year":"2009","unstructured":"Mallon L, Broman J-E, Hetta J (2009) Is usage of hypnotics associated with mortality? Sleep Med 10:279\u2013286. \n                    https:\/\/doi.org\/10.1016\/j.sleep.2008.12.004","journal-title":"Sleep Med"},{"key":"4851_CR16","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.euroneuro.2015.07.006","volume":"25","author":"A Palmaro","year":"2015","unstructured":"Palmaro A, Dupouy J, Lapeyre-Mestre M (2015) Benzodiazepines and risk of death: results from two large cohort studies in France and UK. Eur Neuropsychopharmacol 25:1566\u20131577. \n                    https:\/\/doi.org\/10.1016\/j.euroneuro.2015.07.006","journal-title":"Eur Neuropsychopharmacol"},{"key":"4851_CR17","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2147\/DHPS.S28804","volume":"4","author":"WS Waring","year":"2012","unstructured":"Waring WS (2012) Clinical use of antidepressant therapy and associated cardiovascular risk. Drug Healthc Patient Saf 4:93\u2013101. \n                    https:\/\/doi.org\/10.2147\/DHPS.S28804","journal-title":"Drug Healthc Patient Saf"},{"key":"4851_CR18","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1002\/lary.24479","volume":"124","author":"AV Vroegop","year":"2014","unstructured":"Vroegop AV, Vanderveken OM, Boudewyns AN, Scholman J, Saldien V, Wouters K, Braem MJ, van de Heyning PH, Hamans E (2014) Drug-induced sleep endoscopy in sleep-disordered breathing: report on 1,249 cases. Laryngoscope 124:797\u2013802. \n                    https:\/\/doi.org\/10.1002\/lary.24479","journal-title":"Laryngoscope"},{"key":"4851_CR19","doi-asserted-by":"publisher","first-page":"e0172750","DOI":"10.1371\/journal.pone.0172750","volume":"12","author":"LN Gonzalez Castro","year":"2017","unstructured":"Gonzalez Castro LN, Mehta JH, Brayanov JB, Mullen GJ (2017) Quantification of respiratory depression during pre-operative administration of midazolam using a non-invasive respiratory volume monitor. PLoS One 12:e0172750. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0172750","journal-title":"PLoS One"},{"key":"4851_CR20","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/JCP.0000000000000545","volume":"36","author":"K Zivin","year":"2016","unstructured":"Zivin K, Kim HM, Yosef M, Maust DT, Valenstein M, Smith EG, Davydow DS (2016) Antidepressant medication treatment and risk of death. J Clin Psychopharmacol 36:445\u2013452. \n                    https:\/\/doi.org\/10.1097\/JCP.0000000000000545","journal-title":"J Clin Psychopharmacol"},{"key":"4851_CR21","doi-asserted-by":"publisher","first-page":"2942","DOI":"10.1001\/jama.290.22.2942","volume":"290","author":"DJ Vinkers","year":"2003","unstructured":"Vinkers DJ, Gussekloo J, van der Mast RC et al (2003) Benzodiazepine use and risk of mortality in individuals aged 85 years or older. JAMA 290:2942\u20132943. \n                    https:\/\/doi.org\/10.1001\/jama.290.22.2942","journal-title":"JAMA"},{"key":"4851_CR22","first-page":"72","volume":"10","author":"DB Hogan","year":"2003","unstructured":"Hogan DB, Maxwell CJ, Fung TS et al (2003) Prevalence and potential consequences of benzodiazepine use in senior citizens: results from the Canadian Study of Health and Aging. Can J Clin Pharmacol 10:72\u201377","journal-title":"Can J Clin Pharmacol"},{"key":"4851_CR23","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1111\/j.1532-5415.1992.tb01850.x","volume":"40","author":"R Rumble","year":"1992","unstructured":"Rumble R, Morgan K (1992) Hypnotics, sleep, and mortality in elderly people. J Am Geriatr Soc 40:787\u2013791","journal-title":"J Am Geriatr Soc"},{"key":"4851_CR24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1177\/070674371105600609","volume":"56","author":"N Gisev","year":"2011","unstructured":"Gisev N, Hartikainen S, Chen TF, Korhonen M, Bell JS (2011) Mortality associated with benzodiazepines and benzodiazepine-related drugs among community-dwelling older people in Finland: a population-based retrospective cohort study. Can J Psychiatr 56:377\u2013381. \n                    https:\/\/doi.org\/10.1177\/070674371105600609","journal-title":"Can J Psychiatr"},{"key":"4851_CR25","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/1741-7015-11-212","volume":"11","author":"I Jaussent","year":"2013","unstructured":"Jaussent I, Ancelin M-L, Berr C, P\u00e9r\u00e8s K, Scali J, Besset A, Ritchie K, Dauvilliers Y (2013) Hypnotics and mortality in an elderly general population: a 12-year prospective study. BMC Med 11:212. \n                    https:\/\/doi.org\/10.1186\/1741-7015-11-212","journal-title":"BMC Med"},{"key":"4851_CR26","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1345\/aph.1Q589","volume":"46","author":"LH Oderda","year":"2012","unstructured":"Oderda LH, Young JR, Asche CV, Pepper GA (2012) Psychotropic-related hip fractures: meta-analysis of first-generation and second-generation antidepressant and antipsychotic drugs. Ann Pharmacother 46:917\u2013928. \n                    https:\/\/doi.org\/10.1345\/aph.1Q589","journal-title":"Ann Pharmacother"},{"key":"4851_CR27","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1007\/s00198-008-0826-5","volume":"20","author":"S Pouwels","year":"2009","unstructured":"Pouwels S, van Staa TP, Egberts ACG, Leufkens HGM, Cooper C, de Vries F (2009) Antipsychotic use and the risk of hip\/femur fracture: a population-based case\u2013control study. Osteoporos Int 20:1499\u20131506. \n                    https:\/\/doi.org\/10.1007\/s00198-008-0826-5","journal-title":"Osteoporos Int"},{"key":"4851_CR28","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s00198-012-2015-9","volume":"24","author":"V Rabenda","year":"2013","unstructured":"Rabenda V, Nicolet D, Beaudart C, Bruy\u00e8re O, Reginster JY (2013) Relationship between use of antidepressants and risk of fractures: a meta-analysis. Osteoporos Int 24:121\u2013137. \n                    https:\/\/doi.org\/10.1007\/s00198-012-2015-9","journal-title":"Osteoporos Int"},{"key":"4851_CR29","doi-asserted-by":"publisher","first-page":"489","DOI":"10.2147\/CIA.S101832","volume":"11","author":"A Kragh Ekstam","year":"2016","unstructured":"Kragh Ekstam A, Elmst\u00e5hl S (2016) Do fall-risk-increasing drugs have an impact on mortality in older hip fracture patients? A population-based cohort study. Clin Interv Aging 11:489\u2013496. \n                    https:\/\/doi.org\/10.2147\/CIA.S101832","journal-title":"Clin Interv Aging"},{"key":"4851_CR30","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1007\/s00198-018-4632-4","volume":"29","author":"LI Ven van de","year":"2018","unstructured":"van de Ven LI, Klop C, Overbeek JA, de Vries F, Burden AM, Janssen PK (2018) Association between use of antidepressants or benzodiazepines and the risk of subsequent fracture among those aged 65+ in the Netherlands. Osteoporos Int 29:2477\u20132485. \n                    https:\/\/doi.org\/10.1007\/s00198-018-4632-4","journal-title":"Osteoporos Int"},{"key":"4851_CR31","unstructured":"Norwegian Institute of Public Health WHO Collaborating Center for drug Statistics Methodology ATC\/DDD Index. In: \n                    https:\/\/www.whocc.no\/atc_ddd_index\n                    \n                  . Accessed 19 Dec 2018"},{"key":"4851_CR32","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0895-4356(95)00552-8","volume":"49","author":"RM Herings","year":"1996","unstructured":"Herings RM, Stricker BH, de Boer A et al (1996) Current use of thiazide diuretics and prevention of femur fractures. J Clin Epidemiol 49:115\u2013119","journal-title":"J Clin Epidemiol"},{"key":"4851_CR33","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2105\/AJPH.79.3.340","volume":"79","author":"S Greenland","year":"1989","unstructured":"Greenland S (1989) Modeling and variable selection in epidemiologic analysis. Am J Public Health 79:340\u2013349. \n                    https:\/\/doi.org\/10.2105\/AJPH.79.3.340","journal-title":"Am J Public Health"},{"key":"4851_CR34","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/gps.1116","volume":"19","author":"EJ Lenze","year":"2004","unstructured":"Lenze EJ, Munin MC, Dew MA, Rogers JC, Seligman K, Mulsant BH, Reynolds CF (2004) Adverse effects of depression and cognitive impairment on rehabilitation participation and recovery from hip fracture. Int J Geriatr Psychiatry 19:472\u2013478. \n                    https:\/\/doi.org\/10.1002\/gps.1116","journal-title":"Int J Geriatr Psychiatry"},{"key":"4851_CR35","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1001\/jama.2009.50","volume":"301","author":"D Bliuc","year":"2009","unstructured":"Bliuc D, Nguyen ND, Milch VE et al (2009) Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women. JAMA 301:513\u2013521. \n                    https:\/\/doi.org\/10.1001\/jama.2009.50","journal-title":"JAMA"},{"key":"4851_CR36","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1359\/jbmr.091029","volume":"25","author":"ID Cameron","year":"2010","unstructured":"Cameron ID, Chen JS, March LM, Simpson JM, Cumming RG, Seibel MJ, Sambrook PN (2010) Hip fracture causes excess mortality owing to cardiovascular and infectious disease in institutionalized older people: a prospective 5-year study. J Bone Miner Res 25:866\u2013872. \n                    https:\/\/doi.org\/10.1359\/jbmr.091029","journal-title":"J Bone Miner Res"},{"key":"4851_CR37","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s40261-018-0642-4","volume":"38","author":"A Biffi","year":"2018","unstructured":"Biffi A, Scotti L, Rea F et al (2018) Adherence to antidepressants and mortality in elderly patients with cardiovascular disease. Clin Drug Investig 38:593\u2013602. \n                    https:\/\/doi.org\/10.1007\/s40261-018-0642-4","journal-title":"Clin Drug Investig"},{"key":"4851_CR38","doi-asserted-by":"publisher","first-page":"e566","DOI":"10.4088\/JCP.14m09531","volume":"77","author":"A Krivoy","year":"2016","unstructured":"Krivoy A, Balicer RD, Feldman B, Hoshen M, Zalsman G, Weizman A, Shoval G (2016) Adherence to antidepressants is associated with lower mortality: a 4-year population-based cohort study. J Clin Psychiatry 77:e566\u2013e572. \n                    https:\/\/doi.org\/10.4088\/JCP.14m09531","journal-title":"J Clin Psychiatry"},{"key":"4851_CR39","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.parkreldis.2017.07.032","volume":"43","author":"G Shoval","year":"2017","unstructured":"Shoval G, Stubbs B, Balicer RD, Feldman B, Hoshen M, Zalsman G, Sagy R, Hochman E, Weizman A, Krivoy A (2017) Low adherence to antidepressants is associated with increased mortality in Parkinson disease patients. Parkinsonism Relat Disord 43:92\u201396. \n                    https:\/\/doi.org\/10.1016\/j.parkreldis.2017.07.032","journal-title":"Parkinsonism Relat Disord"},{"key":"4851_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1002\/psb.924","volume":"23","author":"SF Gordon","year":"2012","unstructured":"Gordon SF, Dainty C, Smith T (2012) Why and when to withdraw drugs in the elderly and frail. Prescriber 23:47\u201351. \n                    https:\/\/doi.org\/10.1002\/psb.924","journal-title":"Prescriber"},{"key":"4851_CR41","doi-asserted-by":"publisher","first-page":"72","DOI":"10.5414\/CPP46072","volume":"46","author":"P Gallagher","year":"2008","unstructured":"Gallagher P, Ryan C, Byrne S, Kennedy J, O\u2019Mahony D (2008) STOPP (Screening Tool of Older Person\u2019s Prescriptions) and START (Screening Tool to Alert doctors to Right Treatment). Consensus validation. Int J Clin Pharmacol Ther 46:72\u201383","journal-title":"Int J Clin Pharmacol Ther"},{"key":"4851_CR42","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/j.1532-5415.2012.03923.x","volume":"60","author":"American Geriatrics Society 2012 Beers Criteria Update Expert Panel","year":"2012","unstructured":"American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 60:616\u2013631. \n                    https:\/\/doi.org\/10.1111\/j.1532-5415.2012.03923.x","journal-title":"J Am Geriatr Soc"},{"key":"4851_CR43","unstructured":"Scottish Government Polypharmacy Model of Care Group (2018) Polypharmacy guidance, realistic prescribing"},{"key":"4851_CR44","unstructured":"Nederlands Huisartsen Genootschap (NHG) (2012) De Nederlandse Vereniging voor Klinische Geriatrie NVKG, Orde van Medisch Specialisten (OMS) Multidisciplinaire richtlijn polyfarmacie bij ouderen, \n                    https:\/\/www.nhg.org\/themas\/publicaties\/multidisciplinaire-richtlijn-polyfarmacie-bij-ouderen\n                    \n                  . Accessed 13 June 2018"},{"key":"4851_CR45","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1080\/10550490590924728","volume":"14","author":"D Kalman","year":"2005","unstructured":"Kalman D, Morissette SB, George TP (2005) Co-morbidity of smoking in patients with psychiatric and substance use disorders. Am J Addict 14:106\u2013123. \n                    https:\/\/doi.org\/10.1080\/10550490590924728","journal-title":"Am J Addict"},{"key":"4851_CR46","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1056\/NEJMsa1211127","volume":"368","author":"MJ Thun","year":"2013","unstructured":"Thun MJ, Carter BD, Feskanich D, Freedman ND, Prentice R, Lopez AD, Hartge P, Gapstur SM (2013) 50-year trends in smoking-related mortality in the United States. N Engl J Med 368:351\u2013364. \n                    https:\/\/doi.org\/10.1056\/NEJMsa1211127","journal-title":"N Engl J Med"},{"key":"4851_CR47","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.4088\/JCP.09r05346blu","volume":"71","author":"A Serretti","year":"2010","unstructured":"Serretti A, Mandelli L (2010) Antidepressants and body weight: a comprehensive review and meta-analysis. J Clin Psychiatry 71:1259\u20131272. \n                    https:\/\/doi.org\/10.4088\/JCP.09r05346blu","journal-title":"J Clin Psychiatry"},{"key":"4851_CR48","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1001\/jamapsychiatry.2014.414","volume":"71","author":"SR Blumenthal","year":"2014","unstructured":"Blumenthal SR, Castro VM, Clements CC, Rosenfield HR, Murphy SN, Fava M, Weilburg JB, Erb JL, Churchill SE, Kohane IS, Smoller JW, Perlis RH (2014) An electronic health records study of long-term weight gain following antidepressant use. JAMA Psychiatry 71:889\u2013896. \n                    https:\/\/doi.org\/10.1001\/jamapsychiatry.2014.414","journal-title":"JAMA Psychiatry"},{"key":"4851_CR49","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S0140-6736(16)30175-1","volume":"388","author":"E Angelantonio Di","year":"2016","unstructured":"Global BMI Mortality Collaboration, Di Angelantonio E, Bhupathiraju S et al (2016) Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents. Lancet 388:776\u2013786. \n                    https:\/\/doi.org\/10.1016\/S0140-6736(16)30175-1","journal-title":"Lancet"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-019-04851-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-04851-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-019-04851-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T19:19:14Z","timestamp":1581103154000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-019-04851-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,8]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["4851"],"URL":"https:\/\/doi.org\/10.1007\/s00198-019-04851-9","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"type":"print","value":"0937-941X"},{"type":"electronic","value":"1433-2965"}],"subject":[],"published":{"date-parts":[[2019,2,8]]},"assertion":[{"value":"7 September 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. de Bruin reports personal fees from Pfizer, personal fees from Novartis, personal fees from Sanofi, outside the submitted work;Dr. Klop has nothing to disclose;Dr. Wyers has nothing to disclose;Dr. Overbeek reports other from Universiteit Utrecht \/ Universitair Medisch Centrum Maastricht, during the conduct of the study; Comment: Employee of the PHARMO Institute for Drug Outcomes Research. This independent research institute performs financially supported studies for government and related healthcare authorities and several pharmaceutical companies. The PHARMO Institute received funding from Universiteit Utrecht \/ Universitair Medisch Centrum Maastricht for this study.Dr. Geusens reports grants and personal fees from Amgen, grants from Pfizer, grants from MSD, grants from UCB, grants from Abbott, grants and personal fees from Lilly, grants from BMS, grants from Novartis, grants from Roche, grants from Will Pharma, outside the submitted work.Dr. van den Bergh reports grants and personal fees from Amgen, grants and personal fees from Eli Lilly, personal fees from UCB, outside the submitted work; .Dr. Driessen has nothing to disclose;Dr. de Vries reports that he supervises a PhD student who is also employed with F. Hoffmann la Roche ltd., Basel, Switzerland. The topic of this PhD is not related to the current manuscript. I have not received any reimbursments or fees for this.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}